173 related articles for article (PubMed ID: 16945832)
21. [Contractility and energy metabolism in human myocardium in normal state and in various stages of cardiac insufficiency].
Shevchuk VH; Frantsuzova SB; Horchakova NO; Plyska OI; Babak VV; Arshynnykova LL; Lazoryshynets VV; Iakymovych VV
Fiziol Zh (1978); 1993; 39(5-6):18-23. PubMed ID: 8045312
[TBL] [Abstract][Full Text] [Related]
22. AMP-activated protein kinase control of energy metabolism in the ischemic heart.
Lopaschuk GD
Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S29-35. PubMed ID: 18719595
[TBL] [Abstract][Full Text] [Related]
23. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model.
Xiang P; Deng HY; Li K; Huang GY; Chen Y; Tu L; Ng PC; Pong NH; Zhao H; Zhang L; Sung RY
Cancer Chemother Pharmacol; 2009 Jan; 63(2):343-9. PubMed ID: 18379782
[TBL] [Abstract][Full Text] [Related]
24. p53-Mediated Repression of the PGC1A (PPARG Coactivator 1α) and APLNR (Apelin Receptor) Signaling Pathways Limits Fatty Acid Oxidation Energetics: Implications for Cardio-oncology.
Saleme B; Das SK; Zhang Y; Boukouris AE; Lorenzana Carrillo MA; Jovel J; Wagg CS; Lopaschuk GD; Michelakis ED; Sutendra G
J Am Heart Assoc; 2020 Aug; 9(15):e017247. PubMed ID: 32750288
[No Abstract] [Full Text] [Related]
25. Glucose metabolism and cancer.
Shaw RJ
Curr Opin Cell Biol; 2006 Dec; 18(6):598-608. PubMed ID: 17046224
[TBL] [Abstract][Full Text] [Related]
26. AMPK control of myocardial fatty acid metabolism fluctuates with the intensity of insulin-deficient diabetes.
Kewalramani G; An D; Kim MS; Ghosh S; Qi D; Abrahani A; Pulinilkunnil T; Sharma V; Wambolt RB; Allard MF; Innis SM; Rodrigues B
J Mol Cell Cardiol; 2007 Feb; 42(2):333-42. PubMed ID: 17188707
[TBL] [Abstract][Full Text] [Related]
27. AMP-activated protein kinase in the heart: role during health and disease.
Arad M; Seidman CE; Seidman JG
Circ Res; 2007 Mar; 100(4):474-88. PubMed ID: 17332438
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin.
Govender J; Loos B; Marais E; Engelbrecht AM
J Pineal Res; 2014 Nov; 57(4):367-80. PubMed ID: 25230823
[TBL] [Abstract][Full Text] [Related]
29. Energetic communication between mitochondria and nucleus directed by catalyzed phosphotransfer.
Dzeja PP; Bortolon R; Perez-Terzic C; Holmuhamedov EL; Terzic A
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10156-61. PubMed ID: 12119406
[TBL] [Abstract][Full Text] [Related]
30. Measuring adriamycin-induced cardiac hemodynamic dysfunction with a proteomics approach.
Cui Y; Piao CS; Ha KC; Kim DS; Lee GH; Kim HK; Chae SW; Lee YC; Park SJ; Yoo WH; Kim HR; Chae HJ
Immunopharmacol Immunotoxicol; 2010 Sep; 32(3):376-86. PubMed ID: 20105085
[TBL] [Abstract][Full Text] [Related]
31. Multiscale and modular analysis of cardiac energy metabolism: repairing the broken interfaces of isolated system components.
Van Beek JH
Ann N Y Acad Sci; 2008 Mar; 1123():155-68. PubMed ID: 18375588
[TBL] [Abstract][Full Text] [Related]
32. Energy metabolism in cardiac remodeling and heart failure.
Azevedo PS; Minicucci MF; Santos PP; Paiva SA; Zornoff LA
Cardiol Rev; 2013; 21(3):135-40. PubMed ID: 22990373
[TBL] [Abstract][Full Text] [Related]
33. AMP-activated protein kinase conducts the ischemic stress response orchestra.
Young LH
Circulation; 2008 Feb; 117(6):832-40. PubMed ID: 18268160
[No Abstract] [Full Text] [Related]
34. Diphenylene iodonium stimulates glucose uptake in skeletal muscle cells through mitochondrial complex I inhibition and activation of AMP-activated protein kinase.
Hutchinson DS; Csikasz RI; Yamamoto DL; Shabalina IG; Wikström P; Wilcke M; Bengtsson T
Cell Signal; 2007 Jul; 19(7):1610-20. PubMed ID: 17391917
[TBL] [Abstract][Full Text] [Related]
35. [Optimizing myocardial energy potentials by preoperative high-dose insulin administration for myocardial protection in open-heart surgery].
Haider W; Schütz W; Eckersberger F; Kolacny M
Anaesthesist; 1982 Aug; 31(8):377-82. PubMed ID: 6753640
[No Abstract] [Full Text] [Related]
36. Protective effect of saponins from Panax notoginseng against doxorubicin-induced cardiotoxicity in mice.
Liu L; Shi R; Shi Q; Cheng Y; Huo Y
Planta Med; 2008 Feb; 74(3):203-9. PubMed ID: 18260050
[TBL] [Abstract][Full Text] [Related]
37. Effects of dexrazoxane and amifostine on evolution of Doxorubicin cardiomyopathy in vivo.
Bjelogrlic SK; Radic J; Radulovic S; Jokanovic M; Jovic V
Exp Biol Med (Maywood); 2007 Dec; 232(11):1414-24. PubMed ID: 18040065
[TBL] [Abstract][Full Text] [Related]
38. Cardiac expression of adiponectin and its receptors in streptozotocin-induced diabetic rats.
Guo Z; Xia Z; Yuen VG; McNeill JH
Metabolism; 2007 Oct; 56(10):1363-71. PubMed ID: 17884446
[TBL] [Abstract][Full Text] [Related]
39. Regulation of energy metabolism by creatine in cardiac and skeletal muscle cells in culture.
Seraydarian MW; Artaza L
J Mol Cell Cardiol; 1976 Sep; 08(9):669-78. PubMed ID: 972404
[No Abstract] [Full Text] [Related]
40. Signalling in cardiac metabolism.
Lopaschuk GD; Kelly DP
Cardiovasc Res; 2008 Jul; 79(2):205-7. PubMed ID: 18515845
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
